Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

John Carroll

Concepts (438)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Transcatheter Aortic Valve Replacement
49
2022
148
14.290
Why?
Cardiac Catheterization
56
2021
539
12.000
Why?
Foramen Ovale, Patent
31
2021
39
11.530
Why?
Aortic Valve Stenosis
42
2022
297
9.470
Why?
Coronary Angiography
34
2020
333
7.300
Why?
Heart Valve Prosthesis Implantation
23
2021
197
6.880
Why?
Septal Occluder Device
21
2021
46
6.760
Why?
Heart Valve Prosthesis
18
2022
132
5.610
Why?
Echocardiography, Transesophageal
18
2021
92
5.500
Why?
Echocardiography, Three-Dimensional
12
2019
55
5.450
Why?
Stroke
29
2021
949
4.390
Why?
Aortic Valve
32
2022
455
4.340
Why?
Heart Septal Defects, Atrial
11
2020
52
4.250
Why?
Mitral Valve
15
2021
107
4.030
Why?
Imaging, Three-Dimensional
25
2019
564
3.880
Why?
Registries
34
2022
1866
3.870
Why?
Radiography, Interventional
13
2020
92
3.680
Why?
Radiographic Image Interpretation, Computer-Assisted
16
2019
119
3.630
Why?
Mitral Valve Insufficiency
11
2021
65
3.600
Why?
Ultrasonography, Interventional
11
2020
149
3.160
Why?
Heart Valve Diseases
14
2019
180
3.160
Why?
Secondary Prevention
12
2021
250
2.610
Why?
Treatment Outcome
71
2022
9100
2.520
Why?
Echocardiography, Doppler, Color
8
2019
42
2.470
Why?
Embolism, Paradoxical
7
2020
7
2.120
Why?
Angioplasty, Balloon, Coronary
13
2010
172
1.950
Why?
Fluoroscopy
10
2021
131
1.910
Why?
Heart Defects, Congenital
8
2020
705
1.910
Why?
Cardiac Surgical Procedures
7
2018
472
1.720
Why?
Prosthesis Implantation
6
2019
117
1.710
Why?
Humans
185
2022
113890
1.700
Why?
Coronary Artery Disease
11
2011
678
1.650
Why?
Stents
17
2011
386
1.540
Why?
Thoracic Surgery
10
2021
123
1.540
Why?
Heart Diseases
5
2019
369
1.440
Why?
Catheterization
8
2010
177
1.430
Why?
Coronary Vessels
11
2010
271
1.390
Why?
Predictive Value of Tests
20
2019
1997
1.380
Why?
Heart Injuries
4
2018
29
1.380
Why?
Iatrogenic Disease
3
2018
50
1.370
Why?
Cardiology
12
2022
321
1.350
Why?
Cineangiography
7
2009
20
1.330
Why?
Prostheses and Implants
6
2013
157
1.320
Why?
Hypoxia
4
2020
929
1.290
Why?
Image Enhancement
3
2013
198
1.180
Why?
Radiation Dosage
8
2016
141
1.160
Why?
Societies, Medical
9
2020
766
1.160
Why?
Mitral Valve Stenosis
4
2016
24
1.160
Why?
Ischemic Attack, Transient
3
2015
57
1.140
Why?
Image Processing, Computer-Assisted
8
2015
748
1.130
Why?
Prosthesis Failure
5
2020
115
1.130
Why?
Aged, 80 and over
36
2022
6818
1.110
Why?
Coronary Stenosis
4
2010
45
1.110
Why?
Prosthesis Design
13
2019
243
1.110
Why?
Risk Factors
37
2022
9036
1.110
Why?
Aged
60
2022
20127
1.090
Why?
Male
91
2021
60623
1.050
Why?
Sodium Chloride
2
2015
170
1.020
Why?
Multimodal Imaging
3
2020
102
0.980
Why?
Platelet Aggregation Inhibitors
9
2020
386
0.950
Why?
Percutaneous Coronary Intervention
2
2020
482
0.950
Why?
Fibrinolytic Agents
5
2021
241
0.950
Why?
Contrast Media
6
2015
423
0.950
Why?
Female
83
2022
62822
0.920
Why?
Tomography, X-Ray Computed
9
2020
2381
0.920
Why?
Technology Transfer
1
2021
14
0.910
Why?
United States
39
2022
12446
0.880
Why?
Computed Tomography Angiography
3
2020
76
0.860
Why?
Device Removal
4
2012
114
0.850
Why?
Randomized Controlled Trials as Topic
9
2021
1154
0.810
Why?
Embolism
3
2019
42
0.810
Why?
Time Factors
20
2022
7011
0.810
Why?
Risk Assessment
17
2021
3177
0.790
Why?
Surgery, Computer-Assisted
4
2009
61
0.790
Why?
Coronary Occlusion
1
2019
14
0.780
Why?
Mitral Valve Annuloplasty
1
2019
5
0.770
Why?
Lacerations
1
2019
27
0.760
Why?
Postoperative Complications
11
2021
2154
0.760
Why?
Echocardiography
9
2020
620
0.760
Why?
Product Surveillance, Postmarketing
4
2015
66
0.750
Why?
Dyspnea
1
2020
187
0.750
Why?
Technology Assessment, Biomedical
2
2015
27
0.730
Why?
Shock, Cardiogenic
1
2019
59
0.730
Why?
Balloon Occlusion
3
2014
22
0.720
Why?
Middle Aged
44
2021
28776
0.710
Why?
Thrombosis
4
2012
267
0.710
Why?
Atrial Fibrillation
4
2020
359
0.710
Why?
Surgeons
4
2022
150
0.710
Why?
Radiographic Image Enhancement
5
2009
65
0.700
Why?
Inferior Wall Myocardial Infarction
1
2017
2
0.690
Why?
Heart Rupture, Post-Infarction
1
2017
3
0.690
Why?
Papillary Muscles
1
2017
18
0.680
Why?
Patient Selection
10
2019
700
0.670
Why?
Models, Cardiovascular
4
2008
185
0.660
Why?
ST Elevation Myocardial Infarction
1
2017
49
0.650
Why?
Therapy, Computer-Assisted
2
2014
60
0.640
Why?
Migraine Disorders
4
2021
199
0.630
Why?
Aortography
1
2016
46
0.620
Why?
Multidetector Computed Tomography
1
2016
29
0.620
Why?
Aorta
3
2009
408
0.620
Why?
Diagnostic Imaging
3
2010
294
0.610
Why?
Consensus
9
2021
448
0.600
Why?
Echocardiography, Stress
1
2015
27
0.600
Why?
Severity of Illness Index
11
2021
2845
0.590
Why?
Embolization, Therapeutic
2
2007
100
0.590
Why?
Retrospective Studies
22
2021
11544
0.590
Why?
Heart Ventricles
3
2018
725
0.590
Why?
Exercise Test
3
2015
605
0.590
Why?
Aortic Valve Insufficiency
1
2015
51
0.570
Why?
Foreign-Body Migration
2
2012
33
0.550
Why?
Heart Septal Defects, Ventricular
3
2009
38
0.550
Why?
Radiation Injuries
1
2015
131
0.540
Why?
Reoperation
6
2021
542
0.540
Why?
Heart Septal Defects
3
2008
10
0.540
Why?
Health Policy
1
2017
357
0.530
Why?
Balloon Valvuloplasty
1
2013
5
0.520
Why?
Hospital Mortality
11
2021
854
0.520
Why?
Surgical Instruments
1
2012
43
0.480
Why?
Aortic Rupture
1
2012
12
0.480
Why?
Incidence
10
2021
2449
0.480
Why?
Reproducibility of Results
13
2021
2921
0.470
Why?
Triiodobenzoic Acids
2
2011
16
0.460
Why?
Coronary Disease
5
2009
444
0.450
Why?
Models, Anatomic
2
2009
101
0.450
Why?
Coronary Restenosis
2
2009
22
0.440
Why?
Adult
28
2021
31958
0.430
Why?
Myocardial Infarction
8
2008
1131
0.430
Why?
Sensitivity and Specificity
8
2019
1931
0.430
Why?
Catheter Ablation
2
2018
327
0.430
Why?
Algorithms
9
2010
1514
0.430
Why?
Heart Atria
5
2012
124
0.430
Why?
Medicare
6
2022
642
0.420
Why?
Angiography
4
2019
159
0.420
Why?
Prospective Studies
14
2021
6292
0.420
Why?
Computer Simulation
5
2008
926
0.420
Why?
Equipment Design
5
2014
526
0.400
Why?
Coronary Thrombosis
1
2009
26
0.390
Why?
Angiocardiography
1
2009
1
0.390
Why?
Follow-Up Studies
14
2019
4927
0.380
Why?
Rotation
4
2011
134
0.370
Why?
Anticoagulants
4
2021
534
0.370
Why?
Myocardial Revascularization
1
2009
101
0.370
Why?
Clinical Decision-Making
4
2019
279
0.360
Why?
Evidence-Based Medicine
4
2019
725
0.360
Why?
Drug-Eluting Stents
1
2009
71
0.360
Why?
Heart Septum
1
2008
31
0.360
Why?
Oxygen
1
2013
879
0.360
Why?
Ventricular Septum
1
2007
11
0.360
Why?
Stroke Volume
2
2009
525
0.350
Why?
Migraine with Aura
1
2008
18
0.350
Why?
Survival Rate
12
2021
1852
0.350
Why?
Monitoring, Intraoperative
1
2007
36
0.350
Why?
Echocardiography, Doppler
1
2008
122
0.350
Why?
Patient Simulation
1
2008
35
0.340
Why?
Practice Guidelines as Topic
5
2019
1525
0.340
Why?
Pericardium
1
2007
58
0.330
Why?
Fistula
1
2007
24
0.330
Why?
Coronary Artery Bypass
1
2009
268
0.330
Why?
Catheters, Indwelling
1
2007
87
0.330
Why?
Health Status
3
2021
780
0.320
Why?
Hemostatic Techniques
1
2007
55
0.320
Why?
Advisory Committees
2
2018
214
0.320
Why?
Comprehension
1
2008
169
0.320
Why?
Wounds, Penetrating
1
2007
79
0.320
Why?
Hemodynamics
6
2020
1103
0.320
Why?
Clinical Competence
6
2019
917
0.320
Why?
Blood Vessel Prosthesis
2
2006
65
0.320
Why?
Hemorrhage
4
2018
585
0.320
Why?
Recurrence
6
2021
975
0.310
Why?
Reconstructive Surgical Procedures
1
2009
252
0.310
Why?
Aortic Diseases
1
2007
96
0.300
Why?
Ischemia
1
2009
315
0.300
Why?
Equipment Failure
3
2012
127
0.300
Why?
Recovery of Function
3
2019
613
0.300
Why?
Immunoglobulin Fab Fragments
6
2008
68
0.290
Why?
Cohort Studies
7
2021
4993
0.290
Why?
Patient Readmission
4
2019
646
0.290
Why?
Aneurysm, False
1
2005
36
0.290
Why?
Ventricular Function, Left
1
2009
493
0.290
Why?
N-Acetylmuramoyl-L-alanine Amidase
1
2004
6
0.290
Why?
Aortic Aneurysm
1
2005
51
0.280
Why?
Equipment Safety
1
2004
43
0.280
Why?
Education, Medical
1
2008
247
0.270
Why?
Healthcare Disparities
2
2020
476
0.270
Why?
Antibodies, Antiphospholipid
1
2004
21
0.270
Why?
Antiphospholipid Syndrome
1
2004
28
0.260
Why?
Anatomy, Cross-Sectional
1
2003
12
0.260
Why?
Automation
2
2016
77
0.250
Why?
Magnetic Resonance Angiography
1
2005
237
0.240
Why?
Ventricular Dysfunction, Left
1
2006
385
0.240
Why?
Aspirin
3
2020
327
0.240
Why?
Practice Patterns, Physicians'
3
2019
1236
0.240
Why?
Pacemaker, Artificial
2
2020
112
0.240
Why?
Renal Insufficiency
1
2003
125
0.230
Why?
Hospitals, High-Volume
2
2019
48
0.230
Why?
Arteries
1
2003
236
0.230
Why?
Decompression Sickness
1
2021
3
0.230
Why?
Mycobacterium tuberculosis
1
2004
281
0.220
Why?
Prognosis
5
2021
3539
0.220
Why?
Observer Variation
4
2011
334
0.220
Why?
Cost-Benefit Analysis
3
2019
553
0.220
Why?
Quality of Health Care
3
2019
647
0.220
Why?
Learning Curve
2
2019
64
0.220
Why?
Health Resources
2
2019
139
0.220
Why?
Cardiovascular Agents
3
2014
128
0.210
Why?
Minimally Invasive Surgical Procedures
2
2014
141
0.210
Why?
Thromboembolism
1
2021
100
0.210
Why?
Length of Stay
4
2020
1066
0.200
Why?
American Heart Association
2
2019
289
0.200
Why?
Databases, Factual
3
2020
1169
0.200
Why?
Colorado
4
2019
4484
0.200
Why?
Computer Systems
2
2009
54
0.200
Why?
Image Interpretation, Computer-Assisted
2
2015
263
0.200
Why?
Rural Health Services
1
2020
114
0.190
Why?
Delivery of Health Care, Integrated
2
2019
238
0.190
Why?
Pattern Recognition, Automated
3
2010
80
0.190
Why?
Neurologists
1
2019
16
0.190
Why?
Hospitals, Low-Volume
1
2019
28
0.190
Why?
Popliteal Artery
2
2009
49
0.190
Why?
Electrocardiography, Ambulatory
1
2019
65
0.190
Why?
Comparative Effectiveness Research
1
2020
141
0.190
Why?
Anatomic Landmarks
1
2019
24
0.190
Why?
Patient-Specific Modeling
1
2019
35
0.190
Why?
Heart Valves
1
2019
51
0.190
Why?
Software
2
2016
521
0.190
Why?
Atrioventricular Block
1
2019
44
0.190
Why?
Cardiopulmonary Bypass
1
2020
246
0.190
Why?
Antibodies, Monoclonal
6
2008
1288
0.180
Why?
Treatment Failure
3
2009
334
0.180
Why?
Angioplasty, Balloon
2
2011
71
0.180
Why?
Hospital Costs
1
2019
124
0.180
Why?
Magnetic Resonance Imaging
2
2007
3146
0.180
Why?
Angiotensin Receptor Antagonists
1
2018
82
0.180
Why?
Bioprosthesis
1
2018
42
0.180
Why?
Young Adult
6
2021
10971
0.180
Why?
Models, Organizational
2
2019
159
0.170
Why?
Heart Block
1
2018
51
0.170
Why?
Diagnostic Errors
2
2010
158
0.170
Why?
Intention to Treat Analysis
2
2017
72
0.170
Why?
Proportional Hazards Models
3
2019
1172
0.170
Why?
Coronary Circulation
2
2007
169
0.170
Why?
Risk
3
2019
938
0.170
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2018
227
0.170
Why?
Research Report
1
2017
78
0.160
Why?
France
1
2016
35
0.160
Why?
Disease Management
2
2021
603
0.160
Why?
Single-Blind Method
2
2017
290
0.160
Why?
Personal Satisfaction
1
2018
181
0.160
Why?
Radiologic Health
1
2015
5
0.150
Why?
Patient Safety
2
2019
303
0.150
Why?
Atrial Pressure
1
2015
2
0.150
Why?
Radiation Exposure
1
2016
45
0.150
Why?
Atrial Function, Right
1
2015
13
0.150
Why?
Valsalva Maneuver
1
2015
12
0.150
Why?
Tachycardia, Ventricular
1
2018
181
0.150
Why?
Netherlands
1
2015
71
0.150
Why?
Adolescent
6
2021
18580
0.150
Why?
Pulmonary Wedge Pressure
1
2015
72
0.150
Why?
Movement
2
2009
270
0.140
Why?
Heart Rate
2
2011
840
0.140
Why?
Education, Medical, Graduate
1
2019
386
0.140
Why?
Intersectoral Collaboration
1
2015
60
0.140
Why?
Area Under Curve
1
2015
322
0.140
Why?
Blood Vessel Prosthesis Implantation
3
2004
103
0.140
Why?
Patient Care Team
1
2019
533
0.130
Why?
Clinical Protocols
1
2015
243
0.130
Why?
Four-Dimensional Computed Tomography
1
2014
35
0.130
Why?
Cardiac Catheters
1
2013
17
0.130
Why?
Multicenter Studies as Topic
3
2022
222
0.130
Why?
Atrial Septum
1
2013
4
0.130
Why?
ROC Curve
1
2015
494
0.130
Why?
Punctures
1
2013
38
0.130
Why?
Health Services Accessibility
1
2020
796
0.130
Why?
X-Rays
2
2010
27
0.130
Why?
Kidney Failure, Chronic
1
2019
499
0.130
Why?
Societies
1
2013
41
0.130
Why?
Global Health
1
2016
347
0.120
Why?
Propensity Score
3
2019
248
0.120
Why?
Hospitals
1
2017
492
0.120
Why?
Pancreaticoduodenectomy
1
2014
133
0.120
Why?
Ultrasonography
2
2008
783
0.120
Why?
Cardiovascular Diseases
1
2004
1670
0.120
Why?
Femoral Artery
2
2013
161
0.120
Why?
United States Food and Drug Administration
1
2013
184
0.120
Why?
Blood Pressure
2
2011
1728
0.120
Why?
Research Design
1
2018
935
0.120
Why?
Forecasting
2
2016
386
0.110
Why?
Phantoms, Imaging
4
2010
142
0.110
Why?
Quality Improvement
2
2019
943
0.110
Why?
Europe
2
2009
329
0.110
Why?
Models, Statistical
1
2016
672
0.110
Why?
Electrocardiography
2
2014
654
0.110
Why?
Stress, Mechanical
2
2003
476
0.110
Why?
Automation, Laboratory
1
2010
8
0.100
Why?
Radiology, Interventional
1
2010
20
0.100
Why?
Data Collection
1
2013
673
0.100
Why?
Mitral Valve Prolapse
1
2009
7
0.100
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2009
26
0.100
Why?
Heart
1
2014
695
0.100
Why?
Hospitals, Veterans
1
2011
275
0.100
Why?
Cause of Death
3
2018
388
0.100
Why?
Artifacts
2
2009
116
0.100
Why?
Patient Reported Outcome Measures
2
2021
211
0.100
Why?
Artificial Intelligence
2
2010
98
0.100
Why?
Cardiovascular Surgical Procedures
1
2009
40
0.090
Why?
Peripheral Vascular Diseases
1
2009
96
0.090
Why?
Equipment Failure Analysis
1
2009
133
0.090
Why?
Infant, Newborn
1
2019
5014
0.090
Why?
Nose
1
2008
53
0.090
Why?
Robotics
1
2009
77
0.090
Why?
Prevalence
2
2018
2392
0.090
Why?
Ticlopidine
1
2008
68
0.090
Why?
Heart Failure
2
2018
1936
0.090
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
2
2005
25
0.090
Why?
Leg
1
2009
251
0.090
Why?
Endpoint Determination
1
2008
70
0.090
Why?
Motion
2
2010
98
0.090
Why?
Sirolimus
1
2009
185
0.090
Why?
Cardiac Tamponade
1
2007
17
0.090
Why?
Linear Models
1
2010
884
0.080
Why?
Wakefulness
1
2008
164
0.080
Why?
Quality of Life
4
2021
2197
0.080
Why?
Injections
1
2007
166
0.080
Why?
Natriuretic Peptide, Brain
1
2006
98
0.080
Why?
Quality Indicators, Health Care
2
2019
314
0.080
Why?
Thoracotomy
1
2006
88
0.080
Why?
Double-Blind Method
2
2008
1670
0.070
Why?
Age Factors
2
2020
3271
0.070
Why?
Muramic Acids
1
2004
1
0.070
Why?
Acetylmuramyl-Alanyl-Isoglutamine
1
2004
14
0.070
Why?
Pulmonary Artery
1
2011
1082
0.070
Why?
Peptidoglycan
1
2004
25
0.070
Why?
Ions
1
2004
71
0.070
Why?
Cell Wall
1
2004
50
0.070
Why?
Feasibility Studies
1
2007
747
0.070
Why?
Open Reading Frames
1
2004
118
0.070
Why?
Probability
1
2005
334
0.070
Why?
Whole-Body Irradiation
1
2004
77
0.070
Why?
Portasystemic Shunt, Transjugular Intrahepatic
1
2004
31
0.070
Why?
Genome, Bacterial
1
2004
105
0.070
Why?
Informed Consent
1
2005
160
0.070
Why?
Shear Strength
1
2003
66
0.070
Why?
Cloning, Molecular
1
2004
581
0.060
Why?
Thrombophilia
1
2004
72
0.060
Why?
Kaplan-Meier Estimate
2
2017
883
0.060
Why?
Thrombocytopenia
1
2005
189
0.060
Why?
Diagnosis, Differential
1
2007
1399
0.060
Why?
Patient Care Planning
1
2003
159
0.060
Why?
Diabetes Complications
1
2005
234
0.060
Why?
Angioplasty
1
2002
26
0.060
Why?
Elasticity
1
2003
200
0.060
Why?
Numbers Needed To Treat
1
2021
9
0.060
Why?
Polymorphism, Single Nucleotide
1
2009
1741
0.060
Why?
Japan
1
2022
96
0.060
Why?
Creatinine
1
2003
453
0.060
Why?
Child
2
2012
17710
0.050
Why?
Curriculum
1
2008
820
0.050
Why?
Computational Biology
1
2004
500
0.050
Why?
Patient-Centered Care
1
2006
490
0.050
Why?
Acute Disease
1
2003
989
0.050
Why?
Florida
1
2020
82
0.050
Why?
Patient Discharge
2
2004
787
0.050
Why?
Drug Therapy, Combination
2
2017
1011
0.050
Why?
Escherichia coli
1
2004
797
0.050
Why?
Syndrome
1
2021
340
0.050
Why?
Base Sequence
1
2004
2280
0.050
Why?
Population Density
1
2020
96
0.050
Why?
Norepinephrine
1
2001
268
0.050
Why?
Epinephrine
1
2001
185
0.050
Why?
Travel
1
2020
108
0.050
Why?
Cardiac Care Facilities
1
2019
15
0.050
Why?
Cost Savings
1
2019
83
0.050
Why?
Cardiac Imaging Techniques
1
2019
20
0.050
Why?
Decision Making
1
2006
795
0.050
Why?
Credentialing
1
2019
13
0.050
Why?
Molecular Sequence Data
1
2004
3015
0.050
Why?
Trauma Severity Indices
1
2019
141
0.050
Why?
Health Care Surveys
1
2021
588
0.050
Why?
Terminology as Topic
1
2020
206
0.050
Why?
Models, Econometric
1
2018
34
0.050
Why?
Insurance, Health, Reimbursement
1
2019
95
0.040
Why?
Renin-Angiotensin System
1
2018
84
0.040
Why?
Inpatients
2
2016
351
0.040
Why?
Residence Characteristics
1
2020
284
0.040
Why?
Adrenergic beta-Antagonists
1
2001
369
0.040
Why?
Workload
1
2019
135
0.040
Why?
Risk Management
1
2018
96
0.040
Why?
Markov Chains
1
2018
122
0.040
Why?
Child, Preschool
1
2012
9618
0.040
Why?
United Kingdom
1
2018
227
0.040
Why?
Reference Values
1
2019
855
0.040
Why?
Altitude
1
2001
418
0.040
Why?
Intraoperative Complications
1
2018
128
0.040
Why?
Mortality
1
2018
324
0.040
Why?
Quality Assurance, Health Care
1
2019
377
0.040
Why?
Biomarkers
1
2006
3468
0.040
Why?
Renal Dialysis
1
2019
362
0.040
Why?
Congresses as Topic
1
2016
204
0.040
Why?
Survival Analysis
1
2018
1406
0.030
Why?
Medicaid
1
2018
394
0.030
Why?
Models, Theoretical
1
2019
611
0.030
Why?
Venous Thromboembolism
1
2017
195
0.030
Why?
Karnofsky Performance Status
1
2014
38
0.030
Why?
Duodenal Neoplasms
1
2014
11
0.030
Why?
Spatio-Temporal Analysis
1
2014
33
0.030
Why?
Comorbidity
1
2019
1631
0.030
Why?
Bile Duct Neoplasms
1
2014
54
0.030
Why?
Radiation
1
2013
26
0.030
Why?
Logistic Models
1
2018
2051
0.030
Why?
Constriction, Pathologic
1
2011
180
0.030
Why?
Torsion, Mechanical
1
2009
8
0.030
Why?
Combined Modality Therapy
2
2005
1217
0.030
Why?
Laparoscopy
1
2014
392
0.030
Why?
Radiotherapy Planning, Computer-Assisted
1
2010
131
0.020
Why?
Patient Satisfaction
1
2013
609
0.020
Why?
Exercise
1
2001
1746
0.020
Why?
Calibration
1
2009
139
0.020
Why?
Posture
1
2009
190
0.020
Why?
Radiography
1
2010
834
0.020
Why?
Pancreatic Neoplasms
1
2014
703
0.020
Why?
Vascular Surgical Procedures
1
2009
237
0.020
Why?
Biomechanical Phenomena
1
2009
676
0.020
Why?
Myocardial Ischemia
1
2008
311
0.020
Why?
Platelet Count
1
2005
85
0.020
Why?
Age Distribution
1
2005
398
0.020
Why?
Sex Distribution
1
2005
394
0.020
Why?
Patient Admission
1
2004
202
0.020
Why?
Odds Ratio
1
2005
1052
0.010
Why?
Heparin
1
2003
222
0.010
Why?
Myocardial Reperfusion
1
2002
74
0.010
Why?
Cross-Over Studies
1
2003
479
0.010
Why?
Postoperative Care
1
2003
234
0.010
Why?
Prazosin
1
2001
39
0.010
Why?
Adrenergic alpha-Agonists
1
2001
42
0.010
Why?
Adrenergic alpha-Antagonists
1
2001
43
0.010
Why?
Phenylephrine
1
2001
109
0.010
Why?
Health Care Costs
1
2003
405
0.010
Why?
Oxygen Consumption
1
2001
657
0.010
Why?
Carroll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)